Open Beta
TREN
MetriLume
TREN

US marketsVIVS

SEC-sourced researchBeta

VIVS

VivoSim Labs, INC.

Company comparison ↗

Data passport

CIK
0001497253
Exchange
Nasdaq
Business activity
— · SIC 2836
Financial inputs
6/6
Filing date
Oct 6, 2026
SEC registry record
Operating company
Last updated: SEC company ticker catalog ↗SEC Financial Statement Data Sets ↗SEC investment company series and class registry ↗

Annual financial history

Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table.

Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table. Exact amounts and source periods: March 2025: 144,000.0000 USD; March 2026: 131,000.0000 USD144K USD0 USD0March 2025March 2026
VIVS · Exact amounts and source periods · USD
Period endRevenueFiling date
March 2025144,000.0000Jul 14, 2026
March 2026131,000.0000Jul 14, 2026

Annual periods · USD

Period endRevenueNet incomeOperating cash flowTotal assetsTotal liabilitiesFiling date
March 2026131,000.0000-13,843,000.0000-10,827,000.00007,386,000.00008,485,000.0000Jul 14, 2026
March 2025144,000.0000-2,488,000.0000-9,461,000.000014,650,000.00004,158,000.0000Jul 14, 2026

Financial inputs behind the calculation

Financial inputsUSDPeriod endFiling dateForm
RevenueRevenueFromContractWithCustomerExcludingAssessedTax$131KMarch 2026Jul 14, 202610-K
Previous period revenueRevenueFromContractWithCustomerExcludingAssessedTax$144KMarch 2025Jul 14, 202610-K
Net incomeNetIncomeLoss-$13.84MMarch 2026Jul 14, 202610-K
Operating cash flowNetCashProvidedByUsedInOperatingActivities-$10.83MMarch 2026Jul 14, 202610-K
Total assetsAssets$7.39MMarch 2026Jul 14, 202610-K
Total liabilitiesLiabilities$8.49MMarch 2026Jul 14, 202610-K

New filings

Explore methodology ↗